Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer.

However, the classical TIL marker CD8A alone did not differ between cancer and benign lesions and only weakly significant differences were observed between LumA and ER‐negative cancers ( P = 0.018, non‐Bonferroni‐corrected P ‐value).

also in 1,387 other papers